CROSS COUNTRY HEALTHCARE INC (CCRN)
Health Care · Healthcare Staffing Services · NASDAQ
Cross Country Healthcare is a provider of healthcare staffing and workforce management solutions that connects clinicians with hospitals and health systems across the United States.
What CROSS COUNTRY HEALTHCARE INC does
Cross Country Healthcare provides total talent management services, including contingent staffing, permanent placement, and consultative solutions for the healthcare industry. The company places clinical and non-clinical professionals, such as travel nurses, allied health clinicians, and physicians, in various settings including hospitals, schools, outpatient clinics, and government facilities. It also offers proprietary workforce technologies like the Intellify vendor management system and managed service programs (MSP) to help healthcare providers optimize their staffing processes.
Recent developments
On May 6, 2026, the company entered into an agreement to be acquired by KL Criss Cross Intermediate, LLC, which would result in the company being delisted from the Nasdaq. The first quarter of 2026 saw revenue decline 18% year-over-year while the company continues to focus on disciplined execution and technology initiatives.
From CROSS COUNTRY HEALTHCARE INC's filing of 2026-05-08.
Themes: healthcare workforce solutions, travel nursing, healthcare staffing technology, MSP / VMS services
Fundamentals
- Price$13.25 last close before the listing ended, 2026-07-28
- Market cap$428M as of 2026-04-24 (share count; price 2026-07-28)
- 1-year return-4.1% 2025-07-28 close $13.81 → 2026-07-28 close $13.25
- P/En/a negative earnings
- Net margin-9.0% FY2025, SEC XBRL
- ROE-29.4% FY2025, SEC XBRL
- ROICn/a No figure: its pre-tax income was zero or negative, so there is no tax rate to apply.
- Debt / equityn/a No figure: its filing reports debt under a line we do not read, so a total would be understated.
- Revenue growth (YoY)-21.6% FY2025, SEC XBRL
- Revenue CAGR (3y)-27.8% SEC XBRL
- Beta0.38 as of 2026-09-03
- Last reported earnings2026-05-07 SEC EDGAR Form 8-K (Item 2.02)
No longer listed. This listing has ended. The figures below are historical: the last on record, from 2026-07-28, not a current quote.
How CCRN compares in its sector
- net profit marginmiddle range 432 covered Health Care peers, as of 2026-09-03
- operating marginmiddle range 419 covered Health Care peers, as of 2026-09-03
- return on equitymiddle range 511 covered Health Care peers, as of 2026-09-03
- 3-year revenue CAGRbottom 10% 404 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Quarterly results
| Quarter | Revenue | Operating income | Net income | Diluted EPS | Operating cash flow | Capex |
|---|---|---|---|---|---|---|
| Q1 FY2026 2026-03-31 | $241M | -$4M | -$4M | -$0.14 | $5M | $1M |
| Q4 FY2025 2025-12-31 | $237M | -$72M† | -$83M | -$2.56 | $18M† | $2M† |
| Q3 FY2025 2025-09-30 | $250M | -$6M | -$5M | -$0.15 | $20M† | $2M† |
| Q2 FY2025 2025-06-30 | $274M | -$6M | -$7M | -$0.20 | $4M† | $2M† |
| Q1 FY2025 2025-03-31 | $293M | -$977000 | -$490000 | -$0.02 | $6M | $2M |
| Q4 FY2024 2024-12-31 | $310M | -$3M† | -$4M | -$0.12 | $24M† | $3M† |
| Q3 FY2024 2024-09-30 | $315M | $3M | $3M | $0.08 | $7M† | $1M† |
| Q2 FY2024 2024-06-30 | $340M | -$19M | -$16M | -$0.47 | $82M† | $3M† |
† Not filed as a discrete quarter: derived from the company's own year-to-date figures (for example the fourth quarter as the fiscal year minus the first nine months). A derived per-share figure is approximate, because the share count moves within the year.
Balance sheet at 2026-03-31
- Cash and equivalents$106M
- Total debtnot shown the filing reports its long-term debt in a form we do not read yet
From the company's own SEC 10-Q and 10-K filings (XBRL), re-read every week. Figures in US dollars as filed; informational only — not financial advice.
Analyst consensus
- Consensus ratingHold (3.00 mean, 1=Strong Buy…5=Strong Sell) — 4 analysts
- Mean price target$12.44 range $10.00 – $13.25; median $13.25
Analyst estimates, as of 2026-08-18. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for CCRN
- Consensus EPS estimate$0.01667 next reporting period, as of 2026-08-18
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
- Significant concentration of credit risk within its customer base, notably healthcare systems.
- High sensitivity to healthcare staffing demand fluctuations and potential impact on volume and pricing.
- Risks associated with pending merger and potential delisting from public markets.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days, of which we have read Form 4 filings through 2026-10-20. The 5 days since 2026-10-20 have not been checked yet.
Most recent open-market transaction: 2026-03-11. Based on Form 4 filings read through 2026-10-20; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about CCRN's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding CCRN as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 4,411,858
- Reported value $41,471,468
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 2 increased, 3 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about CCRN's institutional holders → See what each manager we track holds →
Short interest (FINRA)
CCRN had 824,403 shares of reported short interest as of the 2026-07-15 FINRA settlement date (delayed, bi-monthly; not real-time).
CCRN had 2.55% of its shares outstanding sold short as of the 2026-07-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 1.74 days to cover at the same settlement.
- Reported short interest (shares) 824,403
- Short interest (% of shares outstanding) 2.55%
- Prior settlement (shares) 871,295
- Reported change -5.38%
- Days to cover (reported) 1.74
Reported to FINRA as of the 2026-07-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- AMN Healthcare (AMN)
- Aya Healthcare
- Medical Solutions
- CHG Healthcare Services
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare CCRN vs…
Frequently asked questions
What does CROSS COUNTRY HEALTHCARE INC (CCRN) do?
Cross Country Healthcare provides total talent management services, including contingent staffing, permanent placement, and consultative solutions for the healthcare industry. The company places clinical and non-clinical professionals, such as travel nurses, allied health clinicians, and physicians, in various settings including hospitals, schools, outpatient clinics, and government facilities.
What sector is CROSS COUNTRY HEALTHCARE INC (CCRN) in?
CROSS COUNTRY HEALTHCARE INC (CCRN) is classified in the Health Care sector. Its industry is Healthcare Staffing Services. It trades on NASDAQ.
Who are CROSS COUNTRY HEALTHCARE INC's (CCRN) competitors?
Notable peers of CROSS COUNTRY HEALTHCARE INC (CCRN) include AMN Healthcare, Aya Healthcare, Medical Solutions and CHG Healthcare Services. This peer set is informational only — not financial advice.
Where does stocks-llm's data on CCRN come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. This listing has ended, so these are the last figures on record rather than current ones — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are the last daily closes recorded before this listing ended.
Last updated 2026-07-28.
Informational only — NOT financial advice. All figures are the last on record before this listing ended, from SEC EDGAR & market data, shown with their as-of date.